Index of Handouts

Plenary Session 1: Novel Insights in the Biology of Allergic Responses in Immunotherapy
1-1: Personalized Medicine in Allergy and Asthma | Elliot Israel (United States)
Plenary Session 1: Novel Insights in the Biology of Allergic Responses in Immunotherapy
1-2: Biologic Basis of the Allergic Response | Bruce S. Bochner (United States)
Plenary Session 1: Novel Insights in the Biology of Allergic Responses in Immunotherapy
1-3: Overview of Allergen Immunotherapy and Tolerance | Cezmi Akdis (Switzerland)
Plenary Session 1: Novel Insights in the Biology of Allergic Responses in Immunotherapy
1-4: New Treatments for Allergen Immunotherapy | Mübeccel Akdis (Switzerland)
Biologics Track 1: Overview and Newer Uses of Anti-IgE
1-6: New Strategies with Anti-IgE in Allergic Diseases | Stephen T. Holgate (United Kingdom)
Biologics Track 1: Overview and Newer Uses of Anti-IgE
1-7: Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment for Food Allergy | Dale Umetsu (United States)
Biologics Track 1: Overview and Newer Uses of Anti-IgE
1-8: Anti-IgE in Chronic Urticaria | Sarbjit Saini (United States)
Immunotherapy Track 1: Overview of Immunotherapy
1-11: Speaking the Same Language: Grading System for Subcutaneous Immunotherapy Systemic Reaction | Linda Cox (United States)
Immunotherapy Track 1: Overview of Immunotherapy
1-12: Management of Anaphylaxis during Immunotherapy | Phil Lieberman (United States)
Biologics Track 2: Novel Anti-Cytokines
1-15: Anti-IL-13 Prospects in Asthma | Sally Wenzel (United States)
Immunotherapy Track 2: Sublingual Immunotherapy
1-16: Recommendations for Appropriate Sublingual Immunotherapy Clinical Trials | Giovanni Passalacqua (Italy)
Immunotherapy Track 2: Sublingual Immunotherapy
1-17: Current Status of Sublingual Immunotherapy in the United States | Michael Blaiss (United States)
Immunotherapy Track 2: Sublingual Immunotherapy
1-18: WAO Position Paper Update on Sublingual Immunotherapy | G. Walter Canonica (Italy)
Immunotherapy Track 3: Immunotherapy Targets for Food
1-19: Use of Allergen Components: A New Era in Allergology | Motohiro Ebisawa (Japan)
Immunotherapy Track 3: Immunotherapy Targets for Food
1-20: Oral and Sublingual Immunotherapy for Food Allergy | Wesley Burks (United States)
Immunotherapy Track 3: Immunotherapy Targets for Food
1-21: Epicutaneous Immunotherapy for Food Allergy | Hugh Sampson (United States)
Biologics Track 3: New Directions in Immunotherapy
1-22: Identification of Therapeutic Epitopes from Allergens | Alessandro Sette (United States)
Biologics Track 3: New Directions in Immunotherapy
1-23: Specific Immunoregulatory Epitopes in the Treatment of Allergic Disease | Mark Larché (Canada)
Biologics Track 3: New Directions in Immunotherapy
1-24: New Routes for Allergen Immunotherapy | Thomas Kündig (Switzerland)
Biologics Track 4: Critical Novel Molecules for Allergic Diseases
2-1: Role of Thymic Stromal Lymphopoietin (TSLP) in Allergic Responses | Atsushi Kato (United States)
Biologics Track 4: Critical Novel Molecules for Allergic Diseases
2-3: Advances in Synthetic Peptide Immuno-Regulatory Epitopes | Peter Creticos (United States)
Immunotherapy Track 4: Other Novel Approaches to Immunotherapy
2-4: Intralymphatic Immunotherapy | Gabriela Senti (Switzerland)
Immunotherapy Track 4: Other Novel Approaches to Immunotherapy
2-6: Passive Immunization with Allergen-Specific IgG Antibodies for the Treatment and Prevention of Allergy | Rudolf Valenta (Austria)
Biologics Track 5: Biomarkers, Biosimilars and Selection of Patients
2-7: The Use of Biomarkers in Asthma Clinical Research Trials | Robert Lemanske (United States)
Biologics Track 5: Biomarkers, Biosimilars and Selection of Patients
2-8: Inner City Asthma and Anti-IgE | William Busse (United States)
Biologics Track 5: Biomarkers, Biosimilars and Selection of Patients
2-9: Biosimilars | Sergio Bonini (Italy)
Special Lecture 1: Molecular Mechanisms and Treatment of Hereditary Angioedema (HAE)
2-13: Molecular Mechanisms and Treatment of Hereditary Angioedema (HAE) | Bruce Zuraw (United States)
WAO Junior Member Session 2029: Practical Course on Immunotherapy
2-16: Current Status and Future Perspectives of Immunotherapy in Latin America and Cuba | Alexander Diaz Rodriguez (Cuba)
WAO Junior Member Session 2029: Practical Course on Immunotherapy
2-17: Use of New Technology to Improve Utilization and Adherence to Immunotherapy | Ves Dimov (United States)
WAO & AAAAI Session 2028: Update on Urticaria Guidelines - This session is funded through an educational grant from Genentech
2-18: Overview of Acute and Chronic Urticaria | Bruce Zuraw (United States)
WAO & AAAAI Session 2028: Update on Urticaria Guidelines - This session is funded through an educational grant from Genentech
2-19: Chronic Urticaria: New Management Options | Paul A. Greenberger (United States)